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Summary  In  2011,  Chile  experienced  an  increase  in  the  number  of  cases  of  IMD
caused  by  Neisseria  meningitidis  group  W.  This  epidemiological  scenario  prompted
authorities  to  implement  prevention  strategies.  As  part  of  these  strategies,  the  Insti-
tute  of  Public  Heath  of  Chile  conducted  a cross-sectional  study  to  determine  the
prevalence  of  pharyngeal  carriage  of  N.  meningitidis  in  a  representative  sample  of
healthy  children  and  adolescents  aged  10—19  years.
The  identiﬁcation  of  presumptive  N.  meningitidis  strains  was  performed  by  testing
carbohydrate  utilization  in  the  National  Reference  Laboratory  at  the  ISP.  Association
of  meningococcal  carriage  with  risk  factors  was  analyzed  by  calculating  the  OddsRisk  factors Ratio.  Selected  variables  were  included  in  a  logistic  model  for  risk  analyses.
arriage  of  N.  meningitidis  was  6.5%  (CI:  5.7—7.3%).  OlderThe  prevalence  of  cage  (carriers:  14.2  ±  0.29  vs.  non-carriers:  13.8  ±  0.08  years  old;  p  =  0.009),  cohab-
itation  with  children  (carriers:  0.9  ±  0.13  vs.  non-carriers:  0.7  ±  0.03;  p  =  0.028),
number  of  smoking  cohabitants  (carriers:  0.55  ±  0.13  vs.  non-carriers:  0.44  ±  0.03)
and  frequent  attendance  to  crowded  social  venues  (carriers:  49%  vs.  non-carriers:
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37%;  p  =  0.008)  were  determined  to  favor  carriage.  Statistical  modeling  showed  that
was  associated  with  older  age  (OR:  1.077,  p-value:  0.002)  and
en  (OR:  1.182,  p-value:  0.02).
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Sample size  was  calculated  with  an  estimated
prevalence (proportion)  of  meningococcal  carriage
of 20%  among  this  age  group,  0.01  accuracy,  95%meningococcal  carriage  
cohabitation  with  childr
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nvasive  meningococcal  disease  (IMD)  is  a  public
ealth  priority  worldwide  as  a  major  cause  of  mor-
idity and  mortality  and  its  potential  to  cause
utbreaks [1].  The  epidemiology  of  IMD  is  dynamic
n time  and  presents  geographic  variations.  The
mplementation  of  a  comprehensive  surveillance
ystem that  includes  laboratories  capable  of  car-
ying out  a  wide  range  of  microbiological  and
olecular diagnostic  and  characterization  tech-
iques is  essential  for  an  accurate  identiﬁcation  and
haracterization  of  the  etiological  agent  in  clinical
amples  and  to  assess  the  magnitude  of  the  prob-
em.
The causative  agent  of  IMD,  Neisseria  menin-
itidis, is found  exclusively  in  the  human  naso-
harynx  [2].  A  number  of  studies  have  associated
eningococcal  carriage  with  age,  where  adoles-
ents present  the  highest  carriage  rates.  In  Europe
nd North  America,  the  prevalence  of  meningococ-
al carriage  ranges  from  10%  to  35%  [3—6],  but  the
uration of  carriage  and  the  factors  that  result  in
n individual  developing  the  disease  remain  contro-
ersial  [7,8].
Surveillance  data  collected  in  Chile  show  that
roup B  was  responsible  for  most  of  the  IMD  cases.
owever, in  2011,  the  epidemiological  surveillance
ystems detected  an  increase  in  the  number  of
ases of  group  W  disease.  Prior  to  the  occurrence
f these  cases,  the  surveillance  systems  registered
he lowest  incidence  rate,  0.4  per  100,000  habi-
ants.  In  contrast,  the  case-fatality  rate  showed  a
ising trend  that  peaked  at  15.1%  in  2011.  In  2012,
ncidence rates  of  IMD  increased  to  0.8  per  100,000
abitants, and  case  fatality  rates  reached  25.4%.
dditionally,  group  W  was  identiﬁed  in  56%  of  all
egistered  cases,  placing  this  group  as  the  most
revalent [9].
Given  this  new  epidemiological  scenario,  the
inistry of  Health  released  a  health  alert  and
esigned strategies  to  address  the  emergency  [10].
accination was  implemented  in  a  sequential  man-
er throughout  Chile  during  a  period  that  lasted
hree months,  from  October  to  December  2012.
n October,  this  process  began  in  districts  that
c
T
l
aad  the  most  number  of  cases,  and  by  the  end
f December,  infants  between  9 months  and  5
ears of  age  were  covered.  In  Chile,  the  conju-
ated vaccine  has  never  been  used;  only  a clinical
hase II/III  study  was  performed  with  vaccine  B
Novartis  applied  to  adolescents  between  10  and
8 years  of  age).  The  plan  (‘‘Plan  de  Acción  W’’)
lso considered  strengthening  surveillance  systems
nd conducting  epidemiological  studies.
Because  little  information  was  available
egarding circulating  strains  among  asymptomatic
arriers in  Chile,  and  in  the  light  of  the  imple-
entation of  a  vaccination  campaign  with  the
etravalent  conjugate  vaccine  against  groups  A,  C,
 &  Y among  children  up  to  5  years  and  high-risk
opulations,  the  ISP,  in  collaboration  with  the
inistry  of  Health,  Regional  Ministerial  Secretaries
f Health  (SEREMI)  and  Regional  Secretaries  of
ducation  decided  to  conduct  a  carriage  study
mong children  and  adolescents  not  targeted  by
he vaccination  campaign.  This  carriage  study
as realized  in  adolescents  4  months  after  imple-
enting  vaccination  by  means  of  the  established
rogram.
The objectives  of  the  study  were  (i)  to  deter-
ine the  prevalence  of  pharyngeal  carriage  of  N.
eningitidis  in  healthy  children  and  adolescents
ged 10—19  years,  (ii)  to  obtain  the  distribution  of
roups from  pharyngeal  samples,  and  (iii)  to  explore
actors associated  with  meningococcal  carriage.
ethods
opulation
 cross-sectional  study  was  designed  and  a  repre-
entative  sample  of  healthy  Chilean  children  and
dolescents  aged  10—19  years  old  was  selected.onﬁdence  level  and  considering  10%  loss  [11,12].
he study  was  conducted  in  the  three  most  popu-
ated regions  in  Chile:  Metropolitana,  Valparaíso,
nd Biobío.  The  estimated  sample  size  was  4120
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individuals,  which  were  distributed  proportionally
within each  region  and  age  group  (10—13,  14—17,
18 and  older).
A total  of  19  hospitals,  56  schools,  and  15  uni-
versity campuses  were  selected  in  these  three
regions. First,  public  hospitals  with  a  microbiology
laboratory were  identiﬁed,  and  public  schools  and
universities  located  within  1  km  distance  from  the
hospital were  selected  for  sampling.  These  selec-
tion criteria  ensured  that  samples  were  processed
within 4  h  of  being  collected  [13].
All individuals  who  matched  the  selection  crite-
ria were  invited  to  participate;  this  was  restricted
to healthy  individuals  from  both  genders,  ages  ran-
ging from  10  to  19  years  old,  voluntary  participation
presenting the  appropriately  completed  consent
form. Those  with  a  history  of  IMD  or  chronic  dis-
eases, such  as  diabetes,  kidney  failure  or  liver
disease, congenital  or  acquired  immunodeﬁciency,
and hemato-oncologic  diseases,  those  treated  with
corticoids  for  more  than  seven  days,  those  who  had
used immunosuppressant  drugs  or  antibiotics  in  the
last 30  days,  and  those  previously  vaccinated  with
meningococcal  vaccines  were  excluded.
The  legal  guardians  for  participants  under  18
years old  were  informed  about  the  procedure  and
asked  to  sign  a  consent  form.  These  under-aged
children were  also  given  an  assent  form  to  partici-
pate,  which  in  no  way  substituted  the  consent  form
signed  by  the  guardians.  Participants  18  years  or
older were  given  a  consent  form  to  obtain  their
required authorization.  All  individuals  who  took
part in  the  study  were  asked  to  ﬁll  in  a socio-
demographic  and  risk  factors  survey.
Sample collection
Prior  to  the  start  of  the  study,  all  participating
personnel  received  training  on  sample  collection,
survey administration,  specimen  transportation,
equipment handling,  biosafety  measures  required
for the  culture  and  handling  of  N.  meningitidis
isolates, and  management  of  the  online  platform.
This platform  is  an  informatics  system  that  can  be
accessed  through  a  web  page  and  is  available  dur-
ing any  course  of  time  to  enter  data  collected  for
the study.  Additionally,  all  protocols  were  available
online  for  consultation.  A  pilot  study  was  conducted
in one  of  the  selected  schools  in  order  to  test  all
protocols and  validate  the  data  collection  instru-
ment.  This  analysis  was  included  in  the  ﬁnal  report.
Specimens  were  collected  by  health  profes-
sionals through  a  posterior  pharynx  swab  with  a
sterile cotton  tipped  stick  that  was  immediately
inserted into  a  sterile  tube  with  Amies—Charcoal
transport  media  (COPAN  Italia  S.  p.  A.,  Brescia,
m
a
a
lJ.  Díaz  et  al.
talia).  The  tube  was  labeled  with  the  name  of  the
ndividual,  date,  time  of  specimen  collection  and  an
dentiﬁcation  number.  Samples  were  taken  to  the
ocal microbiology  laboratory  within  4  h  of  being
ollected, following  the  recommendations  of  the
enters for  Disease  Control  and  Prevention  (CDC,
tlanta,  US)  [14].
All  the  information  was  recorded  in  a  web-based
edicated study  database.  Data  were  immediately
oded and  stored,  and  access  was  restricted  only  to
he principal  investigators,  allowing  them  to  follow
ll the  study  phases  in  real  time.
aboratory analysis
pecimens  were  isolated  in  Thayer  Martin  agar
nd 5%  goat  blood  agar  in  the  local  laboratory.
hayer Martin  agar  plates  were  maintained  at  35 ◦C
n humidiﬁed  atmosphere  with  5%  CO2 for  48  h
nd checked  daily.  Five  percent  goat  blood  agar
lates  were  maintained  at  35 ◦C  in  a candle  jar
ith inspection  after  24  h.  Gram  staining  was  per-
ormed at  the  local  level  in  all  isolates  grown  in
hayer Martin  agar,  and  Gram-negative  diplococci
ere sent  to  the  Meningitis  Reference  Labora-
ory at  the  ISP  [14]. Upon  primary  inoculation,
here was  a difference  in  media,  as  the  nutri-
ive goat  blood  agar  exhibits  typical  oropharyngeal
ora growth,  whereas  the  Thayer  Martin  agar,  a
elective  media  for  meningococcus  and  gonococ-
us, inhibits  typical  ﬂora  growth,  permitting  only  N.
eningitidis  growth.  Identiﬁcation  of  presumptive
. meningitidis  strains  was  performed  by testing  for
arbohydrate  utilization.  Group  determination  was
erformed  by  slide  agglutination  with  antisera  for
, B,  C,  W,  Y, X,  Z  and  D.  The  antisera  are  produced
y Becton,  Dickinson  and  Company  (DifcoTM brand).
hen  the  reaction  was  negative  (no  identiﬁcation
f the  group),  the  strain  was  tested  with  real-
ime polymerase  chain  reaction  (RT-PCR)  [14,15]  for
rouping: Duplex  RT-PCR  (A/X)  and  (B/C)  for  A,  B,
 and  X  groups;  simple  RT-PCR  for  W  and  Y  groups.
tatistical analysis
ample  size  calculation  and  selection  were  made
o ensure  representativeness  of  the  population  of
hildren and  adolescents  aged  10—19,  so  that  these
217 subjects  were  representative  of  the  1,293,105
ndividuals who  make  up  the  total  population  of  10-
o 19-year-olds  in  Chile  [15].
Numeric variables  were  described  using  mini-
um values,  quartiles,  maximum  values,  means
nd standard  deviations.  For  categorical  variables,
bsolute  and  relative  frequencies  were  used.  Preva-
ence was  calculated  for  each  region,  age  group
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Table  1  Distribution  of  the  sample  by  age,  gender  and  region.
Region
Valparaíso  (N  =  676)  Biobío  (N  =  840)  Metropolitana  (N  =  2701)  Total  (N  =  4217)
N  (%)a N  (%)a N  (%)a N  (%)a
Age  (years)
10—13  328  (46·0)  384  (46·0)  1209  (46·5)  1921  (46·3)
14—17  247  (48·0)  360  (48·3)  1116  (47·6)  1723  (47·8)
18  and  older  101  (6·0)  96  (5·7)  376  (5·9)  573  (5·9)
Gender
Female  425  (61·7)  322  (36·9)  1695  (62·6)  2442  (57·4)
Male  251  (38·3)  518  (63·1)  1006  (37·4)  1775  (42·6)
Carriage
Carrier  50  (7·9)  52  (6·4)  170  (6·2)  272  (6·5)
Non-carrier  626  (92·1)  788  (93·6)  2531  (93·8)  3945  (93·5)
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female,  but  the  percentage  of  males  was  higher  in
the Biobío  region  (63.1%  vs.  36.9%)  (Table  1).
Gram-negative  diplococci  were  identiﬁed  in  433
(10.3%)  of  the  specimens  at  local  laboratories,  of
which 272  (63%)  were  identiﬁed  as  N.  meningi-
tidis at  the  reference  laboratory.  The  rest  of  the
161 (37%)  specimens  were  distributed  among  N.
sicca (9/161),  N.  cinerea  (1/161),  N.  lactamica
(105/161), N.  mucosa  (1/161),  N.  spp.  (2/161),  N.
subﬂava (4/161),  and  other  bacteria  (39/161).  The
overall carriage  observed  was  6.5%  (CI:  5.7—7.3%)
(Table  2).  The  highest  prevalence  carriage  rate  was
Table  2  Carriage  prevalence  of  Neisseria  meningi-
tidis  with  capsular  group  distribution  in  children  and
adolescents  by  region,  age  group  and  gender.
Prevalence  (95%  CI)a
Neisseria  meningitidis  6.5  (5.7—7.3)
Group
B  1.7  (1.3—2.1)
C  0.8  (0.5—1.1)
W  0.2  (0.06—0.4)
Y  0.6  (0.3—0.8)
Z  0.05  (0.01—0.1)
N/T  3.0  (2.5—3.6)
Region
Valparaíso  7.9  (6.0—10.4)
Bio  Bío  6.4  (4.9—8.3)
Metropolitana  6.2  (5.3—7.2)
Age  group
10—13  5.2  (4.2—6.2)
14—17  7.7  (6.4—8.9)
18  and  older  7.1  (5.0—9.2)a Proportions calculated with expansion factors.
nd  gender  for  the  overall  data.  Association  of
eningococcal  carriage  with  some  risk  factors  was
nalyzed  with  the  chi-squared  test  for  categori-
al variables  and  t-test  for  quantitative  variables
long with  corresponding  p-values.  A  95%  conﬁ-
ence interval  (CI)  for  the  means  and  proportions
as also  calculated.
In order  to  select  the  variables  to  be  included
n the  multivariate  model,  the  Hosmer—Lemeshow
riterion  was  used  [16].  Each  variable  was  included
epending  on  the  univariate  association  with  N.
eningitidis  based  on  a  cutoff  p-value  of  0.25  or
ess in  the  Hosmer—Lemeshow  test.  The  selected
ariables were  included  in  the  multivariate  logistic
egression  model,  which  in  turn  are  ﬁltered  by  a
tepwise procedure  with  a  5%  signiﬁcance  level  of
emoval.  Weighted  logistic  regression  was  used  for
he analysis.  Data  were  analyzed  with  STATA  12.0
oftware.
thical approval
he  study  protocol  was  reviewed  and  approved  by
he Northern  Metropolitan  health  service’s  ethics
ommittee  (Servicio  de  Salud  Metropolitano  Norte).
esults
rom  April  15  to  July  6,  2013,  naso-pharyngeal
wabs  were  collected  from  4217  individuals:  2701
rom Metropolitana,  676  from  Valparaíso,  and  840
rom Biobío;  46.3%  of  the  specimens  belonged  to
ndividuals  aged  10—13  years,  47.8%  to  those  aged
4—17 years  and  5.9%  among  the  18  years  and
lder group.  Age  distribution  was  similar  in  all
hree regions.  Overall,  57.4%  of  participants  were
Gender
Females  6.1  (5.1—7.0)
Males  7.1  (5.9—8.3)
a Calculated with expansion factors.
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Table  3  Carriage  prevalence  of  Neisseria  meningi-
tidis  with  capsular  group  distribution  by  age  group.
(A)  Carriage  prevalence  of  Neisseria  meningitidis  with
capsular  group  distribution  for  children  under  14  years
Under  14  years  old  Prevalence  (95%  CI)a
Neisseria  meningitidis  5.2  (4.3—6.3)
Group
B  1.5  (1.1—2.2)
C  0.7  (0.4—1.2)
W  0.05  (0.01—0.4)
Y  0.3  (0.1—0.7)
Z  0.1  (0.03—0.4)
N/T  2.4  (1.8—3.2)
(B)  Carriage  prevalence  of  Neisseria  meningitidis  with
capsular  group  distribution  for  participants  14  years
and  older
14  years  and  older  Prevalence  (95%  CI)a
Neisseria  meningitidis  7.6  (6.5—8.8)
Group
B  1.9  (1.4—2.6)
C  0.9  (0.6—1.4)
W  0.3  (0.2—0.7)
Y  0.8  (0.5—1.3)
Z  —
N/T  3.5  (2.8—4.4)
a Calculated with expansion factors.
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Table  4  Demographic  characteristics  and  risk  factors  in  ca
Carriers  
Mean  (95%  
Age  14.22  (13.9
Number  of  adults  living  in  the  house  3.0  (2.79—
Number  of  children  living  in  the  house  0.87  (0.74
Number  of  persons  sharing  the  room  0.73  (0.60
Number  of  smoking  cohabitants  0.55(0.42—
Cigarettes  per  day  smoked  as  a  group  2.2  (1.51—
Number  of  people  with  whom  engaged
in  intimate  kissing  in  the  last  30  daysa
0.60  (0.41
Prop.  (95%  
Male  0.47  (0.40
Family  history  of  IMD  (yes)  0.012  (0.0
Respiratory  infection  in  the  last  30  days
(yes)
0.36 (0.30
Exposure  to  intradomiciliary  smoking  0.28  (0.23
Assistance  to  massive  events  in  closed
placesa
0.49  (0.40
Smokea 0.20  (0.14
Alcohol  consumptiona 0.26  (0.20
a Asked of adolescents aged 14 years or older.J.  Díaz  et  al.
bserved  among  those  aged  14—17  years  old  (7.6%
I: 6.5—8.8%)  and  the  lowest  prevalence  was  for  the
0 to  13  years  old  age  group  (5.2%  CI:  4.3—6.3%).
here was  a percentage  increase  for  the  distribu-
ion of  each  capsular  group  in  participants  aged  14
r older  when  compared  to  those  below  14  years
ld (Table  3).
Univariate  analysis  showed  that  age  (car-
iers: 14.2  ± 0.29  vs.  non-carriers:  13.8  ±  0.08
ears old;  p =  0.009),  cohabitation  with  children
n the  household  (carriers:  0.9  ±  0.13  vs.  non-
arriers:  0.7  ± 0.03;  p  = 0.028),  number  of  smoking
ohabitants  (carriers:  0.55  ±  0.13  vs.  non-carriers:
.44 ±  0.03)  and  assistance  with  crowded  venues
nd gathering  events  (49%  vs.  37%;  p =  0.008)
ere all  associated  with  meningococcal  carriage
Table  4).
Logistic regression  analysis  demonstrated  that
he risk  of  carriage  can  increase  7.7%  (p-
alue = 0.002)  per  year  while  cohabitation  with
hildren  in  the  household  increases  the  risk  by  18%
p-value =  0.02)  per  child  (Table  5).  This  study  did
ot show  any  association  of  carriage  with  factors
elated to  overcrowding  or  with  geographic  local-
zation,  as  has  been  reported  previously  [6,28].
onetheless,  when  georeferencing  carriers  of  the
etropolitan  Region,  where  most  of  the  carriers
ere registered,  it  appears  that  carriage  of  all
roups,  including  W,  is  higher  in  the  south  and
outheast area  of  Santiago  (Fig.  1),  where  counties
rriers  and  non-carriers.
Non-carriers
CI)  Mean  (95%  CI)  p-Value
3—14.51)  13.77  (13.69—13.85)  0.009
3.19)  2.8  (2.79—2.88)  0.069
—1.00)  0.73  (0.70—0.76)  0.028
—0.86)  0.64  (0.60—0.67)  0.274
0.69)  0.44  (0.41—0.47)  0.027
2.89)  2.0  (1.85—2.21)  0.382
—0.79)  0.46  (0.42—0.50)  0.044
CI)  Prop.  (95%  CI)  p-Value
—0.53)  0.42  (0.41—0.44)  0.182
04—0.037)  0.017  (0.013—0.022)  0.386
—0.42)  0.36  (0.34—0.37)  0.821
—0.33)  0.25  (0.24—0.27)  0.171
9—0.567)  0.37  (0.35—0.40)  0.008
—0.27)  0.15  (0.13—0.16)  0.069
—0.33)  0.24  (0.22—0.25)  0.218
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Table  5  Multivariate  evaluation  of  risk  factors  for  carriage  of  Neisseria  meningitidis.
Variable  OR  p-Value  95%  Conf.  Interval
(A)  Multivariate  evaluation  of  risk  factors  for  carriage  of  Neisseria  meningitidis
Age  1.077  0.002  1.027—1.129
Number  of  children  living  in  the  household  1.182  0.02  1.027—1.36
(B)  Multivariate  evaluation  of  risk  factors  for  carriage  of  Neisseria  meningitidis  in  children  under  14  years  of  age
Exposure  to  tobacco  in  the  household  0.232  0.013  0.073—0.738
Number  of  smoking  cohabitants 1.784 0.014 1.124—2.832
Number  of  children  living  in  the  household 1.245 0.044 1.006—1.541
(C)  Multivariate  evaluation  of  risk  factors  for  carriage  of  Neisseria  meningitidis  in  children  aged  14  years  and  older
Exposure  to  tobacco  in  the  household  1.47  0.029  1.04—2.078
Gender  (female)  0.663  0.014  0.477—0.922
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ith  high  population  density  and  low  socioeco-
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34,35].iscussion
aboratory  surveillance  information  on  invasive
eningococcal disease  (IMD)  obtained  by  the  ISP
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etween  2006  and  2012  showed  that  in  2011,  Chile
xperienced  an  unexpected  increase  in  the  number
f IMD  cases  caused  by  group  W  primarily  affect-
ng children  aged  5 years  or  less  [17].  Group  W
ecame  the  most  prevalent  group  during  2012,
eplacing the  historically  prevalent  group  B.  The
train responsible  for  this  increase  was  a W:ST-11
18]. The  carriage  study  presented  in  this  work  was
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understanding  of  the  reasons  for  this  sudden  change
and identifying  the  most  appropriate  public  health
intervention  to  prevent  further  spread  of  the  dis-
ease.
Our investigation  was  conducted  in  three  of  the
most populated  regions  in  Chile:  Metropolitana,
Valparaiso  and  Biobio,  where  80%  of  the  cases  have
occurred  [19]. The  overall  meningococcal  carriage
rate among  those  aged  10—19  years  was  lower
than that  observed  among  industrialized  countries
in Europe  and  the  US.  Additionally,  the  carriage  of
group W  strains  among  our  study  cohort  was  found
to be  low  (0.2%).
Nonetheless,  genetic  analysis  of  these  strains
would be  needed  to  ascertain  whether  these  iso-
lates belong  to  the  ST-11  complex.  This  complex
has been  associated  with  a  higher  risk  of  IMD  and
a high  case-fatality  rate  [20,21].  Before  the  emer-
gence of  the  W:ST-11  Hajj-associated  strain,  ST-11
isolates were  mainly  found  to  be  group  C.
Because it  has  been  suggested  that  the  duration
of carriage  varies  among  groups  and  it  is thought
to be  shorter  for  hypervirulent  strains,  the  rapid
transmissibility of  ST-11  strains  could  be  a plausi-
ble explanation  for  the  low  carriage  rates  observed
[25].  In a  carriage  study  implemented  in  the  UK,
two adolescent  cohorts  between  ages  of  15  and  17
were compared  for  group  C  prevalence;  the  ﬁrst
during the  incorporation  of  conjugated  meningo-
coccal vaccine  C  (MCC)  in  1999,  which  consisted  of  a
sample of  14,064,  and  the  second  a  year  after  incor-
poration,  which  consisted  of  a  sample  of  16,583.
The results  showed  a  signiﬁcant  reduction  in  car-
riage only  for  this  group  from  0.45%  to  0.15%  [39].
The results  obtained  encourage  the  inclusion  of
adolescents  in  the  immunization  program.  A  factor
that distinguishes  Chile  from  the  UK  is  the  educa-
tional system  in  Chile,  where  adolescents  continue
to live  in their  homes  instead  of  moving  close  to  col-
lege campuses.  Group  C  strains,  whose  sequential
clone ST-11  has  been  shown  to  be  hypervirulent,  is
associated  with  a  greater  risk  of  death  [40]  and  is
also hyperinvasive,  which  explains  why  the  disease
risk after  infection  is  greater  than  IMD  generated
by other  strains  [20]. The  study  showed  that  car-
riage of  this  strain  was  rare,  yet  disease  rates  were
proportionally  high  [22].
The epidemiological  state  of  IMD  for  group  W:ST-
11 can  be  observed  in  other  countries  as  well.  In
the UK,  from  the  end  of  2014  to  May  2015,  270
cases have  been  conﬁrmed  and  group  W  has  been
responsible  for  25%  of  these  cases  compared  to  15%
in 2013—2014.  However,  this  increase  has  mainly
affected adolescents  between  15  and  19  years  old;
this situation  differs  from  the  one  experimented  in
Chile, where  the  main  group  affected  was  children
p
b
c
tJ.  Díaz  et  al.
etween  9  months  and  4 years  old,  followed  by  the
opulation  between  20  and  59  years  of  age.
Although  N.  meningitidis  group  W  has  only
ecently emerged  in  Chile,  it  has  been  circulating  in
atin America  for  the  last  few  years.  Argentina  and
razil have  experienced  recent  outbreaks  caused
y group  W  strains,  W:ST-11  in  particular,  and  cir-
ulation  has  been  observed  in  their  neighboring
ountries, including  Uruguay  [23,26]  and  Paraguay
Ana Belen  Ibarz-Pavon,  personal  communication).
he increase  of  cases  of  IMD  by  W  in  Chile  led  to
 health  alert  policy  that  included  the  implemen-
ation of  preventive  strategies  focused  on  children
rom  9  months  to  5  years  old,  where  incidence  and
ase fatality  rates  were  the  highest  in  2012,  and
he execution  of  a  study  to  determine  the  preva-
ence of  carriers  of  N.  meningitidis  in  the  group
ged 10—19  years,  including  adolescents,  where  the
symptomatic  carriage  rates  are  known  to  be  higher
han in  other  ages  [6].
This investigation  showed  a low  prevalence  of
arriage  of N.  meningitidis  when  compared  with
imilar  age  groups  in  other  countries  such  as
olombia (6.85%  for  subjects  15—21  years  old)  (Ana
elen Ibarz-Pavon,  personal  communication)  and
razil (9.9%  for  subjects  11—19  years  old)  [27].
tudies  worldwide  have  shown  large  variability  in
he prevalence  of  carriage  of  N.  meningitidis  [28],
eaching ﬁgures  as  high  as  20%  in  adolescents  in
uropean  countries  [3,6,29,30].  Some  conditions
elated  to  the  specimen  collection  and  processing
ould affect  bacterial  recovery  and,  consequently,
nderestimate  the  real  prevalence  [31]. To  mini-
ize these  errors,  quality  control  was  maintained
n real  time  by  the  investigators  through  the  online
latform,  where  they  could  verify  that  all  the
rocesses were  performed  according  to  study  pro-
ocols. Sample  collection  and  laboratory  analysis
ere supervised  by  experts  in  order  to  standardize
ll the  processes.
Our results  demonstrate  some  of  the  same  risk
actors  that  have  been  described  in  other  pub-
ications. The  carriage  of  N.  meningitidis  was
ssociated with  age  and  cohabitation  with  children
n the  household.  Through  logistic  regression  analy-
is, many  variables  were  excluded  from  the  model,
eaving  age  as  a factor  and  discarding  it  as  a  con-
ounding  variable.  Considering  one  overall  model
or the  data,  the  variables  that  remained  statisti-
ally signiﬁcant  demonstrated  a direct  association
ith the  number  of  children  living  in  the  house-
old and  older  ages,  suggesting  that  carriage  is  a
henomenon  related,  among  other  things,  to  some
ehaviors  that  are  more  frequently  observed  or  that
an start  during  adolescence,  facilitating  person-
o-person  transmission  in  this  group  [12,32,33].  By
Ms
a
e
o
i
s
e
e
r
d
b
y
f
v
a
w
p
l
p
a
i
a
p
a
e
u
i
w
m
w
p
r
a
a
v
o
i
c
a
r
i
t
f
t
t
a
c
a
l
t
w
v
t
s
n
i
i
b
v
w
t
l
c
v
f
h
p
e
c
t
t
s
t
A
n
v
n
C
n
M
a
t
C
F
T
e
H
C
N
A
S
C
aeningococcal  carriage  in  Chilean  youth  
eparating  the  model  for  each  age  group,  the  vari-
bles that  remained  statistically  signiﬁcant  were:
xposure  to  tobacco  in  the  household,  number
f smoking  cohabitants,  number  of  children  living
n the  household  and  female  gender.  The  results
uggest that  for  children  less  than  14  years  old,
xposure to  tobacco  in  the  household  is  a  counter
ffect for  N.  meningitidis  carriage  but  has  a higher
isk of  being  a  carrier  in  households  with  more  chil-
ren and  smokers.  This  ﬁnding  may  be  observed
ecause exposure  to  tobacco  in  children  under  14
ears old  is not  directly  related  to  carriage,  unlike
or participants  14  years  or  older  (p-value  =  0.159
s. p-value  =  0.013).  For  older  participants  (14  years
nd above),  exposure  to  tobacco  in  the  household
as a  carriage  risk  factor  and  female  gender  was  a
rotective  factor.
In  the  light  of  the  newly  encountered  epidemio-
ogical situation,  public  health  authorities  devised  a
lan of  action,  ‘‘Plan  de  Acción  W,’’  which  included
 series  of  informative  strategies  and  public  health
nterventions.  This  plan  included  issuing  a  health
lert,  the  implementation  of  a  vaccination  cam-
aign targeting  children  aged  9  months  to  5  years,
 risk  communication  program,  strengthening  the
pidemiological  and  laboratory  surveillance,  and
pdated protocols  for  case  management  and  admin-
stration  of  prophylaxis  to  contacts.
Although the  mechanisms  by  which  colonization
ith N.  meningitidis  leads  to  the  development  of
eningococcal  disease  in  some  individuals  is  not
ell established,  studies  of  meningococcal  carriage
revalence  are  useful  to  provide  authorities  with
elevant  information  regarding  the  effectiveness  of
 vaccination  program  by  comparing  carriage  rates
nd strain  distribution  before  and  after  the  inter-
ention,  or  to  detect  the  circulation  and  emergence
f newly  introduced  strains  in  the  population,  alert-
ng them  before  outbreak  occurs  [36].  In  Chile,  IMD
ases caused  by  N.  meningitidis  group  W  have  had
 sustained  increase,  making  it  the  main  agent  in
egistered  cases  of  IMD  with  the  highest  case  fatal-
ty rates  in  2012  and  2013  [9,37,38].  Although  the
arget group  of  the  vaccination  campaign  was  dif-
erent from  the  group  studied  in  this  investigation,
he information  about  the  number  of  carriers  and
he group  distribution  in  adolescents  will  be  invalu-
ble  to  assess  whether  the  use  of  the  vaccine  among
hildren  under  5  years,  among  whom  carriage  rates
re low,  could  have  a  noticeable  effect  on  circu-
ating meningococcal  strains  among  individuals  not
argeted in  the  current  vaccination  schedule;  it
ill also  help  to  identify  the  need  to  extend  the
accination to  adolescents  to  decrease  the  circula-
ion of  W  strains  and  to  identify  group  replacement
hould this  occur.  Although  group  replacement  has
e
o
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ot  been  reported,  experts  strongly  recommend  the
mplementation  of  carriage  studies  to  assess  herd
mmunity  after  vaccination  and  detect  replacement
y groups  and/or  genetic  variants  not  covered  by
accines [39].
Even  though  carriage  rates  and  adolescent  cases
ere low  for  reasons  explained  previously  (mainly
hat clone  ST-11  is  characterized  by  a  low  preva-
ence of  carriage  and  high  risk  of  disease)  and
ases were  decreasing  in  age  groups  subject  to
accination;  health  authorities  decided  to  rein-
orce integrated  epidemiological  surveillance,  train
ealth teams  and  generate  a  state  of  alert  toward
ossible changes  in  the  epidemiology  of  the  dis-
ase. The  results  in  this  study  permitted  us  to
onﬁrm that  the  populations  were  affected  by
he hypervirulent  and  hyperinvasive  clones.  Never-
heless,  given  the  stability  of  the  epidemiological
tate, it also  permitted  the  authorities  to  main-
ain the  implemented  measures  through  ‘‘Plan  de
cción W’’  and  educate  the  population  without  the
eed to  alter  the  vaccination  scheme  in  which  the
accine  was  incorporated  into  the  regular  vacci-
ation  program  starting  in  the  ﬁrst  year  of  age.
hilean  authorities  decided  not  to  expand  vacci-
ation  to  other  age  groups  for  the  time  being.
olecular and  genetic  analyses  of  group  W strains
re being  carried  out  and  will  provide  us  with  fur-
her information  on  the  emergence  of  this  strain  in
hile.
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